GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Total Assets

Changchun BCHT Biotechnology Co (SHSE:688276) Total Assets : ¥5,091 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Total Assets?

Changchun BCHT Biotechnology Co's Total Assets for the quarter that ended in Mar. 2024 was ¥5,091 Mil.

Warning Sign:

If a company builds assets at 32.9% a year, faster than its revenue growth rate of 5.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Changchun BCHT Biotechnology Co's average Total Assets Growth Rate was 37.30% per year. During the past 3 years, the average Total Assets Growth Rate was 28.70% per year. During the past 5 years, the average Total Assets Growth Rate was 32.90% per year.

During the past 7 years, Changchun BCHT Biotechnology Co's highest 3-Year average Total Assets Growth Rate was 37.60%. The lowest was 28.60%. And the median was 32.45%.

Total Assets is connected with ROA %. Changchun BCHT Biotechnology Co's annualized ROA % for the quarter that ended in Mar. 2024 was 4.78%. Total Assets is also linked to Revenue through Asset Turnover. Changchun BCHT Biotechnology Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.05.


Changchun BCHT Biotechnology Co Total Assets Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Total Assets Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 1,583.34 2,467.52 4,174.64 4,283.55 5,046.24

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,216.09 4,426.69 4,792.56 5,046.24 5,090.70

Changchun BCHT Biotechnology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Changchun BCHT Biotechnology Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=4020.362+1025.876
=5,046

Changchun BCHT Biotechnology Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=4079.338+1011.362
=5,091

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co  (SHSE:688276) Total Assets Explanation

Total Assets is connected with ROA %.

Changchun BCHT Biotechnology Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=242.26/( (5046.238+5090.7)/ 2 )
=242.26/5068.469
=4.78 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Changchun BCHT Biotechnology Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=270.288/( (5046.238+5090.7)/ 2 )
=270.288/5068.469
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Changchun BCHT Biotechnology Co Total Assets Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines